Figures
Abstract
Background
Studying diseases associated with AIDS is essential for establishing intervention strategies because comorbidities can lead to death. The objectives were to describe the frequency of comorbidities and verify their distribution according to demographic, epidemiological and clinical data as well as to classify diseases in children and adolescents with AIDS in Vitória, Brazil.
Methods
A retrospective cohort study was conducted among children with AIDS, as defined according to the criteria established by the Ministry of Health, who acquired HIV via vertical transmission, were aged 0 to 18 years, and were monitored at a referral hospital from January 2001 to December 2011.
Results
A total of 177 patients were included, of whom 97 were female (55%). There were 60 patients (34%) <1 year old, 67 patients (38%) between the ages of 1 and 5, and 50 patients (28%) ≥6 years of age included at the time of admission to the Infectious Diseases Ward. Regarding clinical-immunological classification, 146 patients (82.5%) showed moderate/severe forms of the disease at the time of admission into the Ward, and 26 patients (14.7%) died during the study. The most common clinical signs were hepatomegaly (81.62%), splenomegaly (63.8%), lymphadenopathy (68.4%) and persistent fever (32.8%). The most common comorbidities were anaemia (67.2%), pneumonia/septicaemia/acute bacterial meningitis (ABM) (64.2%), acute otitis media (AOM)/recurrent sinusitis (55.4%), recurrent severe bacterial infections (47.4%) and dermatitis (43.1%). An association between severe clinical-immunological classification and admission to the Ward for children aged less than one year old was found for several comorbidities (p<0.001).
Conclusion
Delayed diagnosis was observed because the majority of patients were admitted to the Infectious Diseases Ward at ≥1 year of age and were already presenting with serious diseases. The general paediatrician should be alert to this possibility to make an early diagnosis in children infected with HIV.
Citation: Moreira-Silva SF, Zandonade E, Frauches DO, Machado EA, Lopes LIA, Duque LL, et al. (2013) Comorbidities in Children and Adolescents with AIDS Acquired by HIV Vertical Transmission in Vitória, Brazil. PLoS ONE 8(12): e82027. https://doi.org/10.1371/journal.pone.0082027
Editor: Nicolas Sluis-Cremer, University of Pittsburgh, United States of America
Received: August 29, 2013; Accepted: October 25, 2013; Published: December 4, 2013
Copyright: © 2013 Moreira-Silva et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The authors have no support or funding to report.
Competing interests: The authors have declared that no competing interests exist.
Introduction
The use of antiretroviral therapy (ART) has reduced the morbidity and mortality of AIDS cases and has altered the pattern of the causes of death in these patients. Therefore, studying the diseases associated with AIDS is an important tool for establishing intervention strategies for this population [1].
The clinical course of AIDS is faster in children than in adults due to their immunological immaturity [2]. Diagnosis in children is a challenge because clinical presentations resemble other common childhood diseases. Clinical manifestations include the following: prolonged or recurrent fever (often considered to be of unknown origin); recurrent or chronic diarrhoea; generalised lymphadenopathy; persistent or chronic cough; recurrent upper respiratory tract infections (URTI), including sinusitis and otitis; recurrent pneumonia; persistent oral candidiasis; delayed somatic growth; skin lesions, especially eczema; hepatosplenomegaly; and delayed neuropsychomotor development [3].
Early diagnosis of HIV infection, both in children born to seropositive mothers before or during pregnancy or childbirth and in children with nonspecific constitutional symptoms who require recurrent medical attention, will determine the prognosis of these children [4]. Children diagnosed as infected with HIV have a higher frequency of infections, and the infections are often more severe. Follow-up of these children is important to educate the families about the seriousness of AIDS and its consequences for quality of life [5].
In the state of Espírito Santo (Brazil) between 1985 and December of 2011, there were 8,505 reported cases of AIDS, and 377 of these cases were in children under the age of 13 years, comprising 4.4% of all cases. Almost all of these cases occurred through vertical transmission. There has been a considerable decrease in this type of exposure in the state of Espírito Santo, as shown by the number of cases observed in children under 5 years of age, which fell from 27 cases in 2000 to 3 cases in 2011. The incidence rate of AIDS in children less than 5 years old in 2011 was 2.49/100.000inhabitant. However, new cases still occur each year, and primary care for expectant mothers should be complete and of better quality [6].
The goal of this study was to describe the frequency of comorbidities and to verify their distributions according to demographic, epidemiological and clinical data for the classification of cases of children and adolescents with AIDS in Vitória, Espírito Santo, Brazil.
Methods
This study was submitted and approved by the Research Ethics Committee of the “Nossa Senhora da Glória” State Children’s Hospital (Hospital Estadual Infantil Nossa Senhora da Glória – HEINSG) under number 50/2009. Children’s parents or legal tutors signed the written informed consent.
A retrospective cohort study was conducted in children infected with HIV through vertical transmission who were observed at a paediatric AIDS referral hospital between January 2001 and December 2011. This hospital is linked to the Unified Health System (Sistema Único de Saúde – SUS) of the state of Espírito Santo, and it is a tertiary referral hospital for urgent care/emergencies and paediatric specialties for populations 0-18 years of age.
The population of this study consisted of all patients with AIDS acquired by HIV vertical transmission, aged 0 to 18 years, with a diagnosis defined according to the criteria established by the Brazilian Ministry of Health [4].
The study protocol considered the follow-up period for patients in the Infectious Diseases Ward and included the collection of demographic information, data related to family and diagnostic condition, plasma HIV viral load, CD4+ T lymphocyte count, congenital syphilis, and comorbidities according to the criteria established by the Centers for Disease Control and Prevention (CDC), in accordance with the period in which they were diagnosed [7]. All of the infections were classified with presumptive or definitive diagnoses according to the criteria used by the Brazilian Ministry of Health to define paediatric AIDS [4]. Suggestive diagnoses were accepted in cases of pulmonary tuberculosis and pneumonia caused by P. jirovecii due to diagnostic difficulty. The invasive bacterial infections considered were pneumonia, septicaemia and meningitis.
The data were processed using the Statistical Package for the Social Sciences (SPSS) for Windows, version 18.0. To evaluate the information about plasma HIV viral load and CD4+ T lymphocyte counts, the means, medians and interquartile ranges (IQRs) were computed. All of the other variables were analysed by calculating the relative frequency. A chi-squared test or Fisher’s exact test, whichever was the most appropriate, was used to measure the association between comorbidities (outcome) and the severity of the clinical-immunological changes as well as age at time of admission to the Infectious Diseases Ward. The level of significance considered was 5%.
Results
This study included 177 patients with AIDS due to HIV vertical transmission; 80 patients (45%) were male, and 97 patients (54.8%) were female. There was a predominance of mixed race (111; 62.7%), and their ages were distributed as follows: 33.9% (60) less than 1 year old, 37.9% (67) between 1 and 5 years old, and 28.2% (50) 6 or more years old. The majority of patients, 124 (70%), came from five municipalities that make up the metropolitan area of Vitória. A total of 106 patients (106/175, 60.6%) lived with their parents. There was no difference rregarding temporal trend analysis of cases of AIDS in children regarding CDC pediatric HIV disease categories (Figure 1).
The median patient follow-up was 5 years, with an interquartile range of 2 to 8 years and a maximum follow-up of 11 years. At the time of admission to the Infectious Diseases Ward, 146 patients (82.5%) showed a moderate/severe clinical-immunological classification (B2, B3, C1, C2, or C3). Diagnosis was made in 75/174 children (43%) due to illness. During this period, there were 26 deaths (14.7%), but two cases were not included in the study, one death occurred after a hospital transfer and one death after treatment abandonment (Table 1). A total of 11 patients (6.2%) were transferred, 8 patients (4.5%) did not continue follow-up and 158 patients (89.3%) continued follow-up, including the 24 deaths occurred during this period.
Variable | Categories | N | % |
---|---|---|---|
Sex | Male | 80 | 45.0 |
Female | 97 | 55.0 | |
Race/colour | Caucasian | 34 | 19.0 |
Black | 30 | 17.0 | |
Mixed Race | 111 | 63.0 | |
Asian | 2 | 1.0 | |
Age at admission to the | Less than 1 year | 60 | 34.0 |
Infectious Diseases Ward | 1 to 5 years | 67 | 38.0 |
6 years or more | 50 | 28.0 | |
Area of residence | Urban | 124 | 70.0 |
Rural | 44 | 24.9 | |
Other states | 9 | 5.1 | |
Caregiver | Father/mother | 106 | 60.6 |
Family members | 44 | 25.1 | |
Adoptive | 11 | 6.3 | |
Institution | 14 | 8.0 | |
Case diagnosis (N=174) | Due to child illness | 75 | 43.0 |
HIV viral load | < 100,000 copies/ml | 72 41.7 | |
≥ 100,000 copies/ml | 102 58.3 | ||
Nadir CD4 < 15% | Yes | 85 | 48.5 |
No | 92 | 52.5 | |
Current situation | Alive | 151 | 85.3 |
Deceased | 26 | 14.7 | |
Clinical-immunological category | A1 | 31 | 17.5 |
A2 | 17 | 9.6 | |
A3 | 2 | 1.1 | |
B1 | 24 | 13.6 | |
B2 | 20 | 11.3 | |
B3 | 11 | 6.2 | |
C1 | 15 | 8.5 | |
C2 | 15 | 8.5 | |
C3 | 42 | 23.7 |
Among the 175 patients with available data on their first CD4+ T lymphocyte counts, the median was 845.0 cells/µL (IQR: 440-1352). The median viral load was 18,000 copies/mL (IQR: 30,900-750,000), and the log median initial HIV viral load was 5.25 (IQR: 4.47 - 5.98). Among the 162 patients with available data on their first CD8+ T lymphocyte counts, the median was 1,270.0 (IQR: 839.0 - 2,091.8).
The main clinical signs shown by patients were hepatomegaly in 81.6% (142/174), splenomegaly in 63.8% (111/174), lymphadenopathy in 68.4% (119/174) and persistent fever in 32.8% (57/174). Regarding the frequency of diagnosed comorbidities, it was observed that chronic anaemia (117/174, 67.2%), a first episode of invasive bacterial infection (pneumonia [PN], acute bacterial meningitis [ABM] or septicaemia [111/173, 64.2%]), acute otitis media (AOM) or recurrent sinusitis (97/175, 55.4%), other episodes of severe bacterial infections (PN, ABM or septicaemia, 82/173, 7.4%), dermatitis (75/174, 43.1%), prolonged diarrhoea or gastroenteritis (GE) (71/174, 40.8%) and candidiasis (60/174, 34.5%) were the most frequent (in decreasing order) and that mycobacterial disease, progressive multifocal leukoencephalopathy and cryptosporidiosis were the least frequent; furthermore, there were no cases of pulmonary herpes simplex or histoplasmosis. There were 24/177 cases (13.6%) of tuberculosis, and the state of immunosuppression in these cases was significant (p=0.001). None of the patients with tuberculosis made use of isoniazid prophylaxis, and only 3 patients with TB/HIV co-infection showed a PPD ≥ 5 mm (Table 2).
Diagnosed comorbidities | N | % |
---|---|---|
Chronic anaemia | 117 | 67.2 |
First episode of PN, ABM or septicaemia | 111 | 64.2 |
Acute otitis media or recurrent sinusitis | 97 | 55.4 |
Recurrent severe bacterial infection | 82 | 47.4 |
Dermatitis | 75 | 43.1 |
Prolonged diarrhoea or gastroenteritis | 71 | 40.8 |
Candidiasis | 60 | 34.5 |
Varicella or herpes zoster | 50 | 28.7 |
Wasting syndrome | 39 | 22.4 |
Pneumocystis | 34 | 19.7 |
Lymphocytic interstitial pneumonia | 34 | 19.2 |
HIV-related hepatitis | 32 | 18.4 |
HIV-related encephalopathy | 25 | 14.4 |
Thrombocytopaenia | 24 | 13.8 |
Tuberculosis | 24 | 13.6 |
Chronic swelling of the parotid gland | 23 | 13.4 |
Cytomegalovirus infection | 17 | 9.7 |
Dyslipidaemia | 12 | 6.9 |
Toxoplasmosis | 12 | 6.9 |
Pancreatitis | 9 | 5.2 |
Cardiomyopathy | 5 | 2.9 |
Congenital syphilis | 5 | 2.8 |
Gingivostomatitis or recurrent herpes | 5 | 2.9 |
The comorbidities that showed a significant difference (p<0.05) in relation to the clinical-immunological classification were as follows: chronic anaemia; a first episode of PN, ABM or septicaemia; prolonged diarrhoea or GE; other episodes of serious bacterial infections; tuberculosis; Pneumocystis jirovecii pneumonia; wasting syndrome; HIV-related encephalopathy; HIV-related hepatitis; thrombocytopenia; candidiasis; and dermatitis (Table 3).
Comorbidity / Clinical-immunological abnormalities | Severe* | Not severe | p-value | ||
---|---|---|---|---|---|
N | % | N | % | ||
Chronic anaemia | 67 | 79.8 | 50 | 55.6 | 0.001 |
Chronic swelling of the parotid gland | 7 | 8.5 | 16 | 17.8 | 0.059 |
Dermatitis | 42 | 50.6 | 33 | 36.3 | 0.040 |
Acute otitis media or recurrent sinusitis | 45 | 53.6 | 52 | 57.1 | 0.373 |
Prolonged diarrhoea or gastroenteritis | 49 | 58.3 | 22 | 24.4 | 0.000 |
HIV-related hepatitis | 21 | 25.3 | 11 | 12.1 | 0.020 |
Thrombocytopaenia | 17 | 20.2 | 7 | 7.8 | 0.015 |
Varicella or herpes zoster | 23 | 27.7 | 27 | 29.7 | 0.454 |
First episode of PN, ABM or septicaemia | 74 | 89.2 | 37 | 41.1 | 0.000 |
Lymphocytic interstitial pneumonia | 20 | 23.8 | 14 | 15.6 | 0.119 |
Tuberculosis | 19 | 22.4 | 5 | 5.4 | 0.001 |
HIV-related encephalopathy | 21 | 25.0 | 4 | 4.4 | 0.000 |
Recurrent severe bacterial infection | 67 | 79.8 | 15 | 16.9 | 0.000 |
Pneumocystis | 31 | 37.3 | 3 | 3.3 | 0.000 |
Pancreatitis | 8 | 9.5 | 1 | 1.1 | 0.013 |
Dyslipidaemia | 7 | 8.4 | 5 | 5.6 | 0.328 |
Candidiasis | 49 | 59.8 | 11 | 12.2 | 0.000 |
Cytomegalovirus infection | 12 | 14.1 | 5 | 5.5 | 0.046 |
Toxoplasmosis | 5 | 5.9 | 7 | 7.8 | 0.424 |
Regarding the patients’ age at the time of admission to the Infectious Diseases Ward (Table 4), children less than one year old showed a difference in the frequency of several diseases to a statistically significant degree: anaemia; a first episode of PN, ABM or septicaemia; prolonged diarrhoea or GE; HIV-related hepatitis; candidiasis; others episodes of severe bacterial infections; Pneumocystis jirovecii pneumonia; wasting syndrome; and dermatitis. Chronic swelling of the parotid gland, lymphadenopathy, and lymphocytic interstitial pneumonia (LIP) were more frequent in children older than one year.
Comorbidity/ Age of admission to service | Less than 1 | 1 to 5 years | 6 or more | p-value | |||
---|---|---|---|---|---|---|---|
N | % | N | % | N | % | ||
Chronic swelling of the parotid gland | 1 | 1.7 | 15 | 22.7 | 7 | 14.6 | 0.003 |
Dermatitis | 29 | 49.2 | 28 | 41.8 | 18 | 37.5 | 0.463 |
Acute otitis media or recurrent sinusitis | 29 | 49.2 | 35 | 52.2 | 33 | 67.3 | 0.133 |
Chronic anaemia | 49 | 83.1 | 44 | 65.7 | 24 | 50.0 | 0.010 |
Prolonged diarrhoea or gastroenteritis | 34 | 57.6 | 20 | 30.3 | 17 | 34.7 | 0.005 |
HIV-related hepatitis | 19 | 32.7 | 10 | 14.9 | 3 | 6.1 | 0.001 |
Varicella or herpes zoster | 13 | 22.4 | 24 | 35.8 | 13 | 26.5 | 0.236 |
First episode of PN, ABM or septicaemia | 44 | 74.6 | 43 | 65.2 | 24 | 50.0 | 0.030 |
Thrombocytopaenia | 9 | 15.2 | 12 | 17.9 | 3 | 6.3 | 0.187 |
Cardiomyopathy | 1 | 1.7 | 2 | 3.0 | 2 | 4.3 | a |
Renal disorder | 0 | 0.0 | 1 | 1.5 | 2 | 4.3 | a |
Lymphocytic interstitial pneumonia | 6 | 10.2 | 17 | 25.4 | 11 | 23.9 | 0.078 |
Tuberculosis | 13 | 21.7 | 6 | 8.9 | 5 | 10.0 | 0.077 |
Cryptococcosis | 2 | 3.4 | 0 | 0.0 | 1 | 2.1 | a |
Cryptosporidiosis | 0 | 0.0 | 1 | 1.5 | 0 | 0.0 | a |
HIV-related encephalopathy | 11 | 18.6 | 11 | 16.4 | 3 | 6.3 | 0.159 |
Histoplasmosis | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | a |
Recurrent severe bacterial infection | 37 | 62.7 | 28 | 41.8 | 17 | 36.2 | 0.012 |
Isosporiasis | 1 | 16.7 | 1 | 1.5 | 0 | 0.0 | a |
Leukoencephalopathy | 0 | 0.0 | 0 | 0.0 | 1 | 2.1 | a |
Lymphoma | 0 | 0.0 | 1 | 1.5 | 1 | 2.1 | a |
Pneumocystis | 20 | 33.9 | 11 | 16.7 | 3 | 6.3 | 0.001 |
Mycobacteriosis | 0 | 0.0 | 1 | 1.5 | 0 | 0.0 | a |
Wasting syndrome | 17 | 28.8 | 11 | 16.4 | 11 | 22.9 | 0.249 |
Pancreatitis | 2 | 3.4 | 2 | 3.0 | 5 | 10.4 | a |
Dyslipidaemia | 2 | 3.4 | 6 | 8.9 | 4 | 8.5 | a |
Candidiasis | 30 | 50.8 | 16 | 24.2 | 12 | 24.5 | 0.002 |
Cytomegalovirus infection | 6 | 10.0 | 8 | 11.9 | 3 | 61.2 | 0.574 |
Toxoplasmosis | 3 | 5.0 | 3 | 4.5 | 6 | 12.5 | a |
Congenital syphilis | 4 | 6.8 | 1 | 1.5 | 0 | 0.0 | a |
Table 5 describes the characteristics of mothers of the 177 children. The type of HIV exposure was sexual transmission in 134 mothers (75.7%), the use of injectable drugs in 16 mothers (9%), blood transfusion in 2 mothers (1.1%) and unknown in 25 mothers (14.2%). In 118 cases (66.7%), maternal HIV was diagnosed after the delivery of the child, and only 12/175 mothers (6.9%) underwent the complete protocol to prevent HIV vertical transmission (gestation/delivery/NB and no breastfeeding). A total of 56/89 mothers (62.9%) breastfed their infants. Regarding antenatal care, 95 mothers (53.7%) had access to antenatal care, but of those, 49 women (51.6%) were diagnosed with HIV after delivery. Delivery was vaginal in 52/86 (60.5%) of these women.
Variable | Categories | N | % |
---|---|---|---|
Category of AIDS exposure of the mother | Sexual | 134 | 75.7 |
Use of injectable drugs | 16 | 9 | |
Transfusion | 2 | 1.1 | |
Unknown | 25 | 14.2 | |
Mother received prenatal care | Yes | 95 | 53.7 |
No | 77 | 43.5 | |
Unknown | 5 | 2.8 | |
Mother’s HIV diagnosis | Prior to delivery | 47 | 26.5 |
At delivery | 9 | 5.1 | |
After delivery | 118 | 66.7 | |
Unknown | 3 | 1.7 | |
Brazilian national PMTCT* | Completed | 12 | 6.9 |
protocol (N=175) | Incomplete or not performed | 163 | 93.1 |
Breastfeeding (N=155) | Yes | 113 | 72.9 |
No | 42 | 27.1 | |
Type of delivery | Vaginal | 105 | 59.2 |
Caesarean | 40 | 22.6 | |
Unknown | 32 | 18.1 | |
Age of the mother | 27 years (±5.89) | Min 15 Max 44 | - |
Discussion
In this study, a high frequency of comorbidities was observed in children treated at a tertiary referral hospital for urgent care/emergencies and paediatric specialties. This high frequency can be explained by this hospital being the main public paediatric referral hospital for AIDS in the state of Espírito Santo, and many children come in at advanced ages with a late diagnosis of HIV exposure/infection. Children infected with HIV by vertical transmission, according to a recent study, exhibit a bimodal clinical progression. Thus, 10-30% of patients, called rapid progressors, begin to show symptoms of AIDS in their first year of life, and a small group of patients, called slow progressors, remain asymptomatic for many years and can even reach school age unaffected [8].
Several children in our study showed moderate and severe manifestations, with 23.7% patients classified as clinical category C3, most of whom had high HIV viral loads. In a meta-analysis of mortality predictors among untreated HIV-infected children in Africa and Brazil, the CD4% and CD4+ T lymphocyte count were the most important predictors of mortality, followed by low body weight for age and haemoglobin level [9]. Other Brazilian studies described clinical symptoms and immunological disorders in children and adolescents infected with HIV and the disease progression [10,11,12,13].
Anaemia was the most prevalent comorbidity in all age groups at the time of admission to the hospital service, and it was more frequent in children less than 1 year old and in severe clinical-immunological category C3 patients. Anaemia was more prevalent in our study and had a statistically significant (p=0.007) association in children with severe clinical-immunological alterations. Recent studies in HIV-positive individuals have shown that anaemia is one of the most common haematological manifestations, some data have suggested that bone marrow suppression is the primary pathophysiological mechanism of anaemia in these patients [14,15]. Bacterial infections were frequent in our sample, more than sixty percent of the children develop at least one episode of bacteraemia, even with ART use, most likely due to a late diagnosis of HIV infection. An American study found a significant decrease in the incidence of bacteraemia and a prolongation of the time to the first episode of bacteraemia after the advent of potent ART [16].
A total of 14% children in our sample presented with tuberculosis (TB). The severe state of immunosuppression in these cases was significant (p=0.001), and tuberculosis was significantly associated with an age at admission to the Infectious Diseases Ward of less than one year (p=0.02). A previous study on the prevalence of AIDS in children diagnosed with active TB in the state of Espírito Santo showed 411 cases of paediatric TB from 2000 to 2006, and 27 of these children (7%) were co-infected with AIDS [17]. In a Chilean study, of 246 children with AIDS due to HIV vertical transmission, six presented with TB/HIV co-infection [18].
Another relatively common manifestation in children with AIDS that is rarely observed in adults is lymphocytic interstitial pneumonia (LIP), which is characterised by diffuse chronic interstitial pneumonia with a follicular lymphocytic infiltrate that may progress to cor pulmonale due to cardiac abnormalities, resulting in a continuous increase in pulmonary vascular resistance [19]. The frequency of LIP in our study was 19.5%, and the LIP was significantly associated with the group of children over one year of age (p=0.001). Pneumocystis jirovecii pneumonia has the highest incidence in HIV-infected children in their first year of life, with most cases occurring between 3 and 6 months of age [1,20].
Reducing vertical HIV transmission becomes viable when infected pregnant women are identified and treated with antiretroviral drugs during pregnancy and delivery, and the newborn infant also is treated at birth [21]. Although Brazilian Government offers free antiretroviral therapy, the proportion of HIV-positive pregnant women who do not have access to the prophylactic measures recommended by the Brazilian national PMTCT protocol, and who ultimately fail to be tested for HIV, remains high, either as a function of the women’s social condition or due to inadequacies in the health-care system. Late detection of HIV infection during antenatal care represents an opportunity to intervene in the case of the HIV-infected patient that is lost, thus limiting the possibilities of reducing the number of pediatric cases caused by vertical transmission [22].
Although retrospective data are not ideal for assessing the occurrence of comorbidities and the association of epidemiological and clinical data, their application is justified because implementing health care assistance for these mothers and children is important to demonstrate the susceptibility of the population to this form of HIV transmission. The possibility of response bias by the mothers cannot be discarded because there is a tendency to give more socially acceptable answers. The lack of accuracy regarding data on monitoring during pregnancy and at childbirth also cannot be excluded.
Despite significant reductions in recent years due to ART, opportunistic diseases are still common in Brazilian children with AIDS, especially bacterial diseases. These data reinforce the need to intensify efforts in preventing vertical transmission, early diagnosis of infection, and better paediatric care. Therefore, paediatricians should always be suspicious of and consider the possibility of an HIV/AIDS diagnosis to make an early diagnosis in HIV-infected children.
Author Contributions
Conceived and designed the experiments: S.F.M-S. E.Z. D.O.F. A.E.M.. Performed the experiments: S.F.M-S. E.Z. D.O.F. E.A.M. L.I.A.L. L.L.D. P.P.Q. A.E.M.. Analyzed the data: S.F.M-S. E.Z. D.O.F. A.E.M.. Contributed reagents/materials/analysis tools: S.F.M-S. E.Z. D.O.F. E.A.M. L.I.A.L. L.L.D. P.P.Q. A.E.M.. Wrote the manuscript: S.F.M-S. E.Z. D.O.F. E.A.M. L.I.A.L. L.L.D. P.P.Q. A.E.M..
References
- 1. Centers for Disease Control and Prevention (2009) Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-Exposed and HIV-Infected. Children - MMWR. Morb and Mortal Weekly Report, 58: 1-166.
- 2. Bagenda D, Nassali A, Kalyesubula I, Sherman B, Drotar D et al. (2006) Health, Neurologic, and Cognitive Status of HIV-Infected, Long Surviving, and Antiretroviral-Naive Ugandan Children. Pediatrics, 117: 729-740. doi:https://doi.org/10.1542/peds.2004-2699. PubMed: 16510653.
- 3. Machado ARL, Silva CLO, Dutra CE, Galvão NAM (1994) AIDS na infância: orientação básica no atendimento [AIDS in childhood: basic guidance for care]. Jornal de Pediatria, 1(70): 5-9.
- 4.
Brasil . da Saúde Ministério.Secretaria de Vigilância em Saúde. Programa Nacional de DST e Aids [Brazil. Ministry of Health. Health Surveillance Agency. National STD and . AIDS Program] (2009). Recomendações para Terapia Antirretroviral em Crianças e Adolescentes Infectados pelo HIV [Recommendations for Antiretroviral Therapy in Children and Adolescents Infected with HIV]: manual de bolso/ Ministério da Saúde, Secretaria de Vigilância em Saúde, . Programa Nacional de DST e Aids [pocket manual / Ministry of Health. Health Surveillance Agency. National STD and . AIDS Program]. – Brasília: Ministério da Saúde, 200 p.: il. – (Série Manuais, n. 85).
- 5. Yoshimoto CE, Diniz EMA, Vaz FAC (2005) Evolução Clínica e Laboratorial de Recém-Nascidos de mães HIV Positivas [Clinical and Laboratory Evolution of Newborns with HIV Positive Mothers]. Rev Assoc Med Bras, 51(2): 100-105. doi:https://doi.org/10.1590/S0104-42302005000200017. PubMed: 15947823.
- 6. SESA ES: Boletim Epidemológico Aids (2011). [Epidemiological Report on AIDS December, 2011]- SINAN – C.E. DST-AIDS. Accessed on December 12, 2012. Available at: . www.saude.es.gov.br.
- 7.
BRASIL.Ministério da Saúde. Secretaria de Vigilância em Saúde. Programa Nacional de DST e Aids [Brazil. Ministry of Health. Health Surveillance Agency. National STD and . AIDS Program] (2003). Critérios de definição de casos de aids em adultos e crianças [Criteria for the definition of AIDS cases in children and adults]. Brasília: Ministério da Saúde, 56p. il. – (Série Manuais n. 60).
- 8. Alfonzo MA, Diaz A, Siciliano L, López MG, Hung A, et al. (2012) Functional state of CD4+ and CD8+ T lymphocytes and their role in the slow progression of HIV infection in pediatric patients. J Pediatr (Rio J), 88: 161–8. PubMed: 22543625 J.), 88(2):161-168. Available: . www.scielo.br/pdf/jped/v88n2/a11v88n2.pdf. PubMed: 22543625.
- 9.
Cross Continents Collaboration for Kids (3Cs4kids), Analysis and Writing Committee (2008). Markers for predicting mortality in untreated HIV-infected children in resource-limited settings: a meta-analysis. AIDS, 22:97-105. ISSN 0269-9370 Q2008 Wolters Kluwer Health.
- 10. Araujo Cardoso CA, Pinto JA, Sanchez Candiani TM, Carvalho IR, Grossi Dantas A, Andrade Goulart EM (2012) Assessment of the Prognostic Value of the World Health Organization Clinical Staging System for HIV/AIDS in HIV-Infected Children and Adolescents in a Cohort in Belo Horizonte, Brazil. Journal of Tropical Pediatrics, 1: 1-7.
- 11. Silva EB, Grotto HZW, Vilela MMS (2001) Aspectos clínicos e o hemograma em crianças expostas ao HIV-1: comparação entre pacientes infectados e soro-reversores [Clinical aspects and complete blood counts in children exposed to HIV-1: comparison between infected patients and seroreverters]. Jornal de Pediatria, 6(77): 503-511.
- 12. Centeville M, Morcillo AM, Barros Filho AA, Silva MTN, Dalbo AA et al. (2005) Lack of association between nutritional status and change in clinical category among HIV-infected children in Brazil. Sao Paulo. Med J, 123(2): 62-65. PubMed: 15947832.
- 13.
Vieira MBC, Cardoso CAA, Carvalho AL, Fonseca EBM, Freire HBM (2008). Perfil das crianças infectadas pelo vírus da Imunodeficiência Humana (HIV), internadas em hospital de referência em infectologia pediátrica de Belo Horizonte/MG, 2003 [Profile of children infected with human immunodeficiency virus. (HIV) admitted to paediatric infectious disease referral hospitals in Belo Horizonte/MG, 2003]. Revista Médica de Minas Gerais, 18(2):82-86.
- 14. Feitosa SMC, Cabral PC (2011) Anemia em pacientes HIV-positivo atendidos em um hospital universitário de Pernambuco – Nordeste do Brasil [Anaemia in HIV-positive patients treated at a university hospital in Pernambuco – Northeast Brazil]. Jornal Brasileiro de Doenças Sexualmente Transmissíveis; 23(2): 69-75. doi:https://doi.org/10.5533/2177-8264-201123204.
- 15.
Daminelli EN, Tritinger A, Spada C (2010). Alterações hematológicas em pacientes infectados pelo vírus da imunodeficência humana submetidos à terapia antirretroviral com e sem inibidor de protease [Haematological abnormalities in patients infected with human immunodeficiency virus on antiretroviral therapy with or without protease inhibitors]. Rev Bras Hematol Hemoter [online journal], 32(1):10-15. Available: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516- 84842010000100006. Epub Mar 19, 2010 http://dx.doi.org/10.1590/S1516-84842010005000007.
- 16. Kapogiannis BG, Soe MM, Nesheim SR, Sullivan KM, Abrams E et al. (2008) Trends in Bacteremia in the Pre-and Post-Highly Active Antiretroviral Therapy Era among HIV-Infected Children in the US Perinatal AIDS Collaborative Transmission Study (1986-2004). Pediatrics; 121: e1229-39.
- 17. Miranda AE, Dietze R, Maciel EL, Prado TN, Caus AL et al. (2011) Tuberculosis and AIDS Co-Morbidity in Children: Linkage of Databases from Espírito Santo State, Brazil. J Trop Pediatr, 57(4): 296-298. doi:https://doi.org/10.1093/tropej/fmq087. PubMed: 20876684.
- 18.
Villarroel JB, Vizueta ER, Álvarez AMP, Galaz MIL, Peña AD et al. (2007) Tuberculosis y SIDA en Pediatría: A propósito de cinco casos [Tuberculosis and AIDS in Paediatrics: an account of five cases]. Rev Chil Infectol, 24(6): 472-476. Available: . http://www.scielo.cl/pdf/rci/v24n6/art07.pdf.
- 19. Moreira-Silva SF, Moreno LMC, Dazzi M, Freire , Miranda AE (2012) Acute cor pulmonale due to lymphocytic interstitial pneumonia in a child with AIDS. Braz J Infect Dis, 16(3): 289-293. doi:https://doi.org/10.1590/S1413-86702012000300013. PubMed: 22729199.
- 20. COMMITTEE ON PEDIATRIC AIDS (1997) Evaluation and Medical Treatment of the HIV-Exposed Infant. Pediatrics, 99(6): 909-917. doi:https://doi.org/10.1542/peds.99.6.909. PubMed: 9190556. Available online at: Available online at: PubMed: 9190556.
- 21. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G et al. (1994) Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med, 331: 1173-1180. doi:https://doi.org/10.1056/NEJM199411033311801. PubMed: 7935654.
- 22.
Souza-Júnior PRB, Szwarcwald CL, Barbosa Júnior A, Carvalho MF, Castilho EA (2004). HIV infection during pregnancy: the Sentinel Surveillance Project, Brazil, 2002. Rev Saude Publica, 38:764-772.